文献速递肝病

非酒精性脂肪性肝炎纤维化发生机制

Mechanisms of Fibrosis Development in Nonalcoholic Steatohepatitis.
PubMed 文献 · Gastroenterology · 2020-02-08

非酒精性脂肪性肝病影响全球20%-25%成人,其中25%进展为非酒精性脂肪性肝炎(NASH),肝纤维化是NASH患者死亡的主要决定因素。本文综述肝细胞-巨噬细胞-肝星状细胞(HSC)交互在NASH纤维化中的作用,聚焦应激/死亡肝细胞驱动促纤维化交互的通路及治疗干预策略。

要点

  • NASH纤维化由肝细胞-巨噬细胞-HSC交互驱动
  • 应激和死亡肝细胞激活TAZ、Notch、Hedgehog等发育通路
  • efferocytosis清除死细胞影响炎症与纤维化

核心结论

  • 肝细胞-巨噬细胞-HSC交互网络是NASH纤维化发生的关键机制,靶向该网络有望治疗NASH。

研究设计与样本

  • 综述,总结肝细胞-巨噬细胞-HSC交互在NASH纤维化中的作用及治疗干预选项。

主要发现

  • NASH患者中肝纤维化是死亡的主要决定因素。
  • 应激和死亡肝细胞通过TAZ、Notch、Hedgehog等发育通路重激活引发促纤维化交互。
  • efferocytosis清除NASH中死亡细胞可能影响炎症和纤维化。
  • 单细胞RNA测序揭示了HSC和巨噬细胞的异质性。

关键数值与推荐

  • 非酒精性脂肪性肝病影响全球20%-25%成年人群。
  • 25%的非酒精性脂肪性肝病患者进展为NASH,增加肝硬化、肝衰竭和肝细胞癌风险。

临床怎么用

  • 关注肝细胞-巨噬细胞-HSC交互作为NASH纤维化的治疗靶点。
  • 考虑efferocytosis和发育通路重激活在NASH纤维化中的作用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Nonalcoholic fatty liver disease is the most prevalent liver disease worldwide, affecting 20%-25% of the adult population. In 25% of patients, nonalcoholic fatty liver disease progresses to nonalcoholic steatohepatitis (NASH), which increases the risk for the development of cirrhosis, liver failure, and hepatocellular carcinoma. In patients with NASH, liver fibrosis is the main determinant of mortality. Here, we review how interactions between different liver cells culminate in fibrosis development in NASH, focusing on triggers and consequences of hepatocyte-macrophage-hepatic stellate cell (HSC) crosstalk. We discuss pathways through which stressed and dead hepatocytes instigate the profibrogenic crosstalk with HSC and macrophages, including the reactivation of developmental pathways such as TAZ, Notch, and hedgehog; how clearance of dead cells in NASH via efferocytosis may affect inflammation and fibrogenesis; and insights into HSC and macrophage heterogeneity revealed by single-cell RNA sequencing. Finally, we summarize options to therapeutically interrupt this profibrogenic hepatocyte-macrophage-HSC network in NASH.

来源:Gastroenterology,查看原文。版权归原作者所有。

引用

  1. Schwabe RF, Tabas I, Pajvani UB, et al. Mechanisms of Fibrosis Development in Nonalcoholic Steatohepatitis. Gastroenterology. 2020. PMID: 32044315. doi:10.1053/j.gastro.2019.11.311

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。